as the partial antiestrogen 1 and the partial estrogen 2 have much lower estrogenic properties than des , but still have strong prostatic tumor inhibiting properties , they may offer a suitable alternative to conventional therapy of prostate carcinoma because of their possibly low estrogenic side effects .
C0014939
estrogen
C0033578
prostatic tumor